Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The microbiota in cirrhosis and its role in hepatic decompensation
Jonel Trebicka, Jane Macnaughtan, Bernd Schnabl, et al.
Journal of Hepatology (2021) Vol. 75, pp. S67-S81
Open Access | Times Cited: 174

Showing 1-25 of 174 citing articles:

Gut microbiome and health: mechanistic insights
Willem M. de Vos, Herbert Tilg, Matthias Van Hul, et al.
Gut (2022) Vol. 71, Iss. 5, pp. 1020-1032
Open Access | Times Cited: 1379
Gut-liver axis: Pathophysiological concepts and clinical implications
Herbert Tilg, Timon E. Adolph, Michael Trauner
Cell Metabolism (2022) Vol. 34, Iss. 11, pp. 1700-1718
Open Access | Times Cited: 340
The gut–liver axis and gut microbiota in health and liver disease
Cynthia L. Hsu, Bernd Schnabl
Nature Reviews Microbiology (2023) Vol. 21, Iss. 11, pp. 719-733
Closed Access | Times Cited: 206
Gut liver brain axis in diseases: the implications for therapeutic interventions
Mengyao Yan, Shuli Man, Benyue Sun, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 73
Microalgae—Sustainable Source for Alternative Proteins and Functional Ingredients Promoting Gut and Liver Health
Yahav Eilam, Hamdan Khattib, Noam Pintel, et al.
Global Challenges (2023) Vol. 7, Iss. 5
Open Access | Times Cited: 45
Randomized, controlled clinical trial of the DIALIVE liver dialysis device versus standard of care in patients with acute-on- chronic liver failure
Banwari Agarwal, Rafael Bañares, Faouzi Saliba, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 79-92
Open Access | Times Cited: 39
Fecal microbiota transplantation in alcohol-associated acute-on-chronic liver failure: an open-label clinical trial
Anima Sharma, Akash Roy, Madhumita Premkumar, et al.
Hepatology International (2022) Vol. 16, Iss. 2, pp. 433-446
Open Access | Times Cited: 53
Update in the Treatment of the Complications of Cirrhosis
Juan G. Abraldeṣ, Paolo Caraceni, Marwan Ghabril, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 21, Iss. 8, pp. 2100-2109
Open Access | Times Cited: 33
Fecal Microbiota Transplantation in Liver Cirrhosis
Adrian Boicean, Victoria Bîrluțiu, Cristian Ichim, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2930-2930
Open Access | Times Cited: 28
Rifaximin for prevention and treatment of hepatic encephalopathy in people with cirrhosis
Harry D Zacharias, Fady Kamel, Jaclyn Tan, et al.
Cochrane library (2023) Vol. 2023, Iss. 7
Closed Access | Times Cited: 22
Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Maja Thiele, Ida Falk Villesen, Lili Niu, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 2, pp. 345-359
Open Access | Times Cited: 12
Research reviews and prospects of gut microbiota in liver cirrhosis: a bibliometric analysis (2001–2023)
Xiaofei Zhu, Ziyuan Zhou, Xiaxia Pan
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 7
Effect of rifaximin on infections, acute‐on‐chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA‐AH)
César Jiménez, Meritxell Ventura‐Cots, Margarita Sala, et al.
Liver International (2022) Vol. 42, Iss. 5, pp. 1109-1120
Open Access | Times Cited: 36
Changing Epidemiology of Cirrhosis and Hepatic Encephalopathy
Jeremy Louissaint, Sasha Deutsch‐Link, Elliot B. Tapper
Clinical Gastroenterology and Hepatology (2022) Vol. 20, Iss. 8, pp. S1-S8
Open Access | Times Cited: 36
Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice
Jennifer T. Wolstenholme, Justin M. Saunders, Maren L. Smith, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 35
Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics
Ji Won Park, Jung Hee Kim, Sung Eun Kim, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1288-1288
Open Access | Times Cited: 33
Gut dysbiosis, endotoxemia and clotting activation: A dangerous trio for portal vein thrombosis in cirrhosis
Francesco Violi, Pasquale Pignatelli, Valentina Castellani, et al.
Blood Reviews (2022) Vol. 57, pp. 100998-100998
Open Access | Times Cited: 29
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injury
Carl-Philipp Hackstein, Jasper Spitzer, Konstantinos Symeonidis, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 1, pp. 150-166
Open Access | Times Cited: 17
Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease
Cynthia L. Hsu, Yanhan Wang, Yi Duan, et al.
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 7, pp. 3059-3069
Closed Access | Times Cited: 16
Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis
Simon Johannes Gairing, Eva Maria Schleicher, Peter R. Galle, et al.
Hepatology Communications (2023) Vol. 7, Iss. 4
Open Access | Times Cited: 16
The pathogenesis of gut microbiota in hepatic encephalopathy by the gut–liver–brain axis
Ruirui Zhu, Liwen Liu, Guizhen Zhang, et al.
Bioscience Reports (2023) Vol. 43, Iss. 6
Open Access | Times Cited: 16
The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
Francisco Barrera, Javier Uribe, Nixa Olvares, et al.
Annals of Hepatology (2024) Vol. 29, Iss. 4, pp. 101501-101501
Open Access | Times Cited: 6
Gut microbiome profiles to exclude the diagnosis of hepatic encephalopathy in patients with cirrhosis
Jasmohan S. Bajaj, Jacqueline G. O’Leary, Simona Jakab, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Simvastatin and Rifaximin in Decompensated Cirrhosis
Elisa Pose, César Jiménez, Giacomo Zaccherini, et al.
JAMA (2025)
Closed Access
Regulatory mechanisms of the probiotic-targeted gut–liver axis for the alleviation of alcohol-related liver disease: a review
Feiyu Yang, Xiangfei Li, Jing Sun, et al.
Critical Reviews in Food Science and Nutrition (2025), pp. 1-22
Closed Access
Page 1 - Next Page

Scroll to top